Sanofi is a global biopharmaceutical company headquartered in Paris, France. It discovers, develops, manufactures, and supplies prescription medicines and vaccines worldwide. The company’s portfolio spans specialty care (including immunology, oncology, and rare diseases), vaccines, and general medicines such as diabetes and cardiovascular treatments, alongside a consumer healthcare business.
Relevant to the chemical and bioprocess industries, Sanofi operates an extensive manufacturing network covering small‑molecule synthesis and formulation, biologics (notably monoclonal antibodies and recombinant proteins), and vaccines, with large‑scale cell culture, fermentation, and sterile fill‑finish capabilities. The company has increasingly focused on high‑value biologics; most of its active pharmaceutical ingredient operations were carved out into EuroAPI in 2022. Sanofi supplies highly regulated markets globally and maintains in‑house expertise in quality control, analytical sciences, and industrial operations.